Overview

A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers

Status:
Not yet recruiting
Trial end date:
2023-08-21
Target enrollment:
Participant gender:
Summary
The main objective of this study is to assess the drug-drug interaction and pharmacokinetics of ABBV-903 and Midazolam in healthy adult participants.
Phase:
Phase 1
Details
Lead Sponsor:
AbbVie
Treatments:
Midazolam